Logical Therapeutics Inc. Announces Results Of Phase 1b Clinical Study Of Its Naproxen Prodrug Logical Therapeutics, Inc., a biotechnology company focused on the development of
medicines that treat diseases associated with poorly controlled inflammation, announced the successful completion of its Phase 1b randomized controlled multi-dose safety and pharmacokinetics study of LT-NS001, the Company's proprietary naproxen prodrug.
Source: www.medicalnewstoday.comActavis Receives Approval Of Generic Wellbutrin XL(R) 300mg In The United States Actavis Group, the international generic pharmaceuticals company, announced that it has received approval from the US Food & Drug Administration to market Bupropion Hydrochloride extended-release tablets (XL) 300mg. Distribution of the product will commence immediately. Bupropion Hydrochloride extended-release tablets (XL), available in 300mg strength, are the generic equivalent of Wellbutrin XL® for the treatment of major depressive disorder.
Source: www.medicalnewstoday.comBioniche Phase III Clinical Trial In Bladder Cancer Progressing Well Bioniche Life Sciences Inc. (TSX: BNC), a research-based, technology-driven Canadian biopharmaceutical company, announced that its first Phase III clinical trial with a formulation of Mycobacterial Cell Wall-DNA Complex (MCC), trademarked Urocidin, for the treatment of bladder cancer, is progressing well. The Data Safety Monitoring Committee held its fifth scheduled meeting regarding this clinical trial on August 14, 2008.
Source: www.medicalnewstoday.comGovernment Of Canada Confirms Funding For Canadian Mental Health Commission The Honourable Tony Clement, Minister of
Health announced that the Government's funding commitment to the Canadian Mental
Health Commission is now confirmed at $130 million over its 10-year mandate. "This funding commitment underscores the Government of Canada's belief in this important initiative to improve the quality of life of Canadians and their families dealing with mental illness," said Minister Clement.
Source: www.medicalnewstoday.comStatement Of APA President Nada Stotland, M.D. On Abortion And Mental Health A recently released report on mental
health and abortion confirms the position of the American Psychiatric Association: abortion is not a risk to a woman's mental
health. APA President Nada Stotland, M.D., an expert on women's mental
health, made the following statement today: "As we have known, there is no convincing evidence that abortion is a significant cause of psychiatric illness. We must distinguish illnesses from feelings.
Source: www.medicalnewstoday.comCrisis Residential Facilities Healthier Than Psychiatric Hospitals? - Study Finds More Mental Health Improvements At Consumer-Managed Program For people with grave psychiatric conditions, consumer-managed residential programs may be the way to go, a new study suggests. Not only are the daily costs of these facilities cheaper than psychiatric hospitals, but patients of these programs may get
healthier than their counterparts in traditional, locked institutions, according to the study, results of which have been published online by the
Source: www.medicalnewstoday.comProPublica Examines U.S. Investigation Into Pharmaceutical Company Ranbaxy Over Antiretrovirals Used In PEPFAR, Other Drugs ProPublica on Thursday examined a U.S. investigation into whether Indian pharmaceutical company Ranbaxy engaged in a "pattern of systemic fraudulent conduct" by concealing its drug manufacturing process violated FDA standards, including HIV/AIDS medications used in the
Source: www.medicalnewstoday.comOxford Researchers Give Protein Production More Precision Oxford researchers have developed a new technique to prepare proteins for use as therapeutic
drugs. The technology, which represents a significant step forward from current production methods, will enable the development of purer and more effective protein-based
drugs. Therapeutic proteins are currently prescribed for the treatment of cancer, heart attacks, cystic fibrosis, strokes, diabetes, anaemia and haemophilia.
Source: www.medicalnewstoday.com
# posted by Network @ 12:00 PM
